Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.

De Los Rios F, Kleindorfer DO, Guzik A, Ortega-Gutierrez S, Sangha N, Kumar G, Grotta JC, Lee JM, Meyer BC, Schwamm LH, Khatri P; SPOTRIAS Investigators.

J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2130-8. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.024. Epub 2014 Aug 10.

PMID:
25113084
[PubMed - in process]
2.

Acute stroke with hyperdense middle cerebral artery sign benefits from IV rtPA.

Tartaglia MC, Di Legge S, Saposnik G, Jain V, Chan R, Bussière M, Hachinski V, Frank C, Hesser K, Pelz D.

Can J Neurol Sci. 2008 Nov;35(5):583-7.

PMID:
19235441
[PubMed - indexed for MEDLINE]
3.

Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?

Ringleb PA, Schellinger PD, Schranz C, Hacke W.

Stroke. 2002 May;33(5):1437-41. Review.

PMID:
11988629
[PubMed - indexed for MEDLINE]
Free Article
4.

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.

Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, Alwell K, Gebel J, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Shukla R, Broderick JP; Neuroscience Institute.

Stroke. 2004 Feb;35(2):e27-9. Epub 2004 Jan 22.

PMID:
14739423
[PubMed - indexed for MEDLINE]
Free Article
6.

Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS network.

Willey JZ, Khatri P, Khoury JC, Merino JG, Ford AL, Rost NS, Gonzales NR, Ali LK, Meyer BC, Broderick JP.

J Stroke Cerebrovasc Dis. 2013 May;22(4):318-22. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.005. Epub 2011 Dec 15.

PMID:
22177935
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Acute stroke management in the elderly.

Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.

Cerebrovasc Dis. 2007;23(4):304-8. Epub 2006 Dec 29.

PMID:
17199089
[PubMed - indexed for MEDLINE]
9.

Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms.

Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force:, Levine SR, Khatri P, Broderick JP, Grotta JC, Kasner SE, Kim D, Meyer BC, Panagos P, Romano J, Scott P; NINDS rt-PA Stroke Trial Investigators.

Stroke. 2013 Sep;44(9):2500-5. doi: 10.1161/STROKEAHA.113.000878. Epub 2013 Jul 11. Review. Erratum in: Stroke. 2014 Mar;45(3):e52.

PMID:
23847249
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set: post hoc analysis of ECASS I.

Hacke W, Bluhmki E, Steiner T, Tatlisumak T, Mahagne MH, Sacchetti ML, Meier D.

Stroke. 1998 Oct;29(10):2073-5.

PMID:
9756584
[PubMed - indexed for MEDLINE]
Free Article
11.

A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.

Boudreau DM, Guzauskas G, Villa KF, Fagan SC, Veenstra DL.

Ann Emerg Med. 2013 Jan;61(1):46-55. doi: 10.1016/j.annemergmed.2012.04.020. Epub 2012 May 24.

PMID:
22633340
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.

Kent DM, Price LL, Ringleb P, Hill MD, Selker HP.

Stroke. 2005 Jan;36(1):62-5. Epub 2004 Nov 29.

PMID:
15569865
[PubMed - indexed for MEDLINE]
Free Article
13.

Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 hours of onset.

Sugiura S, Iwaisako K, Toyota S, Takimoto H.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1061-6. doi: 10.3174/ajnr.A1012. Epub 2008 Mar 27.

PMID:
18372418
[PubMed - indexed for MEDLINE]
Free Article
14.

Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.

Sallustio F, Koch G, Di Legge S, Rossi C, Rizzato B, Napolitano S, Samà D, Arnò N, Giordano A, Tropepi D, Misaggi G, Diomedi M, Del Giudice C, Spinelli A, Fabiano S, Stefanini M, Konda D, Reale CA, Pampana E, Simonetti G, Stanzione P, Gandini R.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e323-31. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.001. Epub 2013 Feb 4.

PMID:
23379980
[PubMed - in process]
15.

Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.

Cronin CA, Langenberg P, Dutta TM, Kittner SJ.

Stroke. 2013 Dec;44(12):3544-6. doi: 10.1161/STROKEAHA.113.002478. Epub 2013 Oct 3.

PMID:
24092551
[PubMed - indexed for MEDLINE]
16.

Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study.

Burns TC, Rodriguez GJ, Patel S, Hussein HM, Georgiadis AL, Lakshminarayan K, Qureshi AI.

AJNR Am J Neuroradiol. 2008 Nov;29(10):1918-24. doi: 10.3174/ajnr.A1236. Epub 2008 Sep 10.

PMID:
18784214
[PubMed - indexed for MEDLINE]
Free Article
17.

Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke?

Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S.

Cerebrovasc Dis. 2004;17(2-3):182-90. Epub 2003 Dec 29.

PMID:
14707420
[PubMed - indexed for MEDLINE]
18.

Slow progressive acceptance of intravenous thrombolysis for patients with stroke by rural primary care physicians.

Leira EC, Pary JK, Davis PH, Grimsman KJ, Adams HP Jr.

Arch Neurol. 2007 Apr;64(4):518-21.

PMID:
17420312
[PubMed - indexed for MEDLINE]
19.

Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor.

Huang P, Chen CH, Yang YH, Lin RT, Lin FC, Liu CK.

Cerebrovasc Dis. 2006;22(5-6):423-8. Epub 2006 Aug 11.

PMID:
16912476
[PubMed - indexed for MEDLINE]
20.

Intravenous tissue plasminogen activator for stroke: a review of the ECASS III results in relation to prior clinical trials.

Cronin CA.

J Emerg Med. 2010 Jan;38(1):99-105. doi: 10.1016/j.jemermed.2009.08.004. Epub 2009 Sep 17. Review.

PMID:
19765940
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk